SAN DIEGO, Aug. 21, 2024 /PRNewswire/ — Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, immuno-oncology and beyond, will be participating in the following upcoming investor…